This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

4 Biotech Stocks Under $10 Moving Higher

Stock quotes in this article: FOLD, CUR, CLDX, ARRY

Neuralstem (CUR)

This is a biotechnology company, which is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. This stock is trading up 10% to $1.20 in recent trading.

Today's Range: $1.09-$1.23

52-Week Range: $0.42-$1.96 Volume: 1.27 million

Three-Month Average Volume: 1.62 million

From a technical perspective, CUR is ripping higher here right off its 50-day moving average of $1.12 with decent volume. This move is quickly pushing CUR within range of triggering a major breakout trade. That trade will hit once CUR mangos to take out some key overhead resistance levels at $1.25 to $1.55 with high volume.

Traders should now look for long-biased trades in CUR as long as it's trending above its 50-day at $1.12, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.62 million shares. If that breakout triggers soon, then CUR will set up to re-test or possibly take out its next major overhead resistance levels at $1.96 to $2.03.

Celldex Therapeutics (CLDX)

This is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. This stock is trading up 5% to $5.99 in recent trading.

Today's Range: $5.71-$6.00

52-Week Range: $2.37-$6.71

Volume: 570,000

Three-Month Average Volume: 689,355

From a technical perspective, CLDX is trending higher here back above its 50-day moving average of $5.88 with decent volume. This move is quickly pushing CLDX within range of triggering a near-term breakout trade. That trade will hit once CLDX manages to take out some near-term overhead resistance levels at $5.97 to $6.18 with high volume. At last check, CLDX has hit an intraday high of $6 and volume is just a bit below its three-month average action of 689,355 shares.

Traders should now look for long-biased trades in CLDX as long as it's trending above its 50-day at $5.88, and then once it sustains a move or close above those breakout levels with volume that hits near or above 689,355 shares. If that breakout triggers soon, then CLDX will set up to re-test or possibly take out its next major overhead resistance levels at $6.71 to $7. Keep in mind that any move above $6.71 will push CLDX into new 52-week high territory, which is bullish technical price action.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,802.27 -2.44 -0.01%
S&P 500 1,939.51 -6.65 -0.34%
NASDAQ 4,410.3860 -11.6990 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs